• Free for qualified executives and consultants to industry

  • Receive quarterly issues of Area Development Magazine and special market report and directory issues


FarmaKeio Custom Compounding Plans Conway, Arkansas, Operations

FarmaKeio Custom Compounding, a pharmaceutical company, plans to establish production operations in Conway, Arkansas. The $2.29 million project is expected to create 74 jobs.

The new 16,000 square-foot facility will provide more space for service and product lines and research, testing, and development. The investment will allow the company to reach more markets with its compounded hormone medications and in-demand peptide medications that support tailored integrative health treatment plans designed for individual patients.

"Today marks a momentous occasion for FarmaKeio as we proudly inaugurate our new Custom Compounding facility in Conway," said Dan DeNeui, CEO of FarmaKeio. "This state-of-the-art facility signifies our unwavering commitment to personalized patient care. We are excited about the possibilities this facility brings and are optimistic about its potential to further enhance our ability to positively impact patient lives.”

FarmaKeio is a custom compounding pharmacy serving practitioners and their patients. The company prepares both sterile and non-sterile prescriptions, certain commercially available medications, and retail and express shipping options in select locations.

“FarmaKeio Custom Compounding is a fast-growing company, and the State of Arkansas is proud to be the home for their next location,” noted Clint O’Neal, executive director of the Arkansas Economic Development Commission (AEDC). “Congratulations to the City of Conway, the Conway Development Corporation, and local stakeholders on this exciting new announcement.”

"We are excited to welcome FarmaKeio to Conway,” added Brad Lacy, president and CEO of the Conway Area Chamber of Commerce and the Conway Development Corporation. “Our diverse local economy has always been a strength of the community and region. FarmaKeio's decision to locate here adds to that diversity and further strengthens our growing manufacturing sector.”

Exclusive Research